86 related articles for article (PubMed ID: 12068134)
1. Expression of cyclin B1 and cdc2 in nodal non-Hodgkin's lymphoma and its prognostic implications.
Jin YH; Park CK
J Korean Med Sci; 2002 Jun; 17(3):322-7. PubMed ID: 12068134
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancer.
Kim DH
Yonsei Med J; 2007 Aug; 48(4):694-700. PubMed ID: 17722244
[TBL] [Abstract][Full Text] [Related]
3. Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma : relationship to cell death, proliferation, and transformation.
Banerjee SK; Weston AP; Zoubine MN; Campbell DR; Cherian R
Am J Pathol; 2000 Jan; 156(1):217-25. PubMed ID: 10623670
[TBL] [Abstract][Full Text] [Related]
4. Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysis.
Leoncini L; Cossu A; Megha T; Bellan C; Lazzi S; Luzi P; Tosi P; Barbini P; Cevenini G; Pileri S; Giordano A; Kraft R; Laissue JA; Cottier H
Int J Cancer; 1999 Oct; 83(2):203-9. PubMed ID: 10471528
[TBL] [Abstract][Full Text] [Related]
5. Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications.
Chae SW; Sohn JH; Kim DH; Choi YJ; Park YL; Kim K; Cho YH; Pyo JS; Kim JH
Yonsei Med J; 2011 May; 52(3):445-53. PubMed ID: 21488187
[TBL] [Abstract][Full Text] [Related]
6. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Obermann EC; Went P; Pehrs AC; Tzankov A; Wild PJ; Pileri S; Hofstaedter F; Dirnhofer S
Oncol Rep; 2005 Dec; 14(6):1461-7. PubMed ID: 16273239
[TBL] [Abstract][Full Text] [Related]
7. Expression of G2-M modulators in thyroid neoplasms: correlation of cyclin A, B1 and cdc2 with differentiation.
Ito Y; Yoshida H; Nakano K; Takamura Y; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Pathol Res Pract; 2002; 198(6):397-402. PubMed ID: 12166896
[TBL] [Abstract][Full Text] [Related]
8. p53 protein expression and its prognostic importance in patients with nodal non-Hodgkin's lymphoma.
Ahn MJ; Kim H; Kim IS; Park JK; Ki MR; Park CK
J Korean Med Sci; 2000 Feb; 15(1):59-64. PubMed ID: 10719810
[TBL] [Abstract][Full Text] [Related]
9. Cdc2 expression in primary thyroid lymphoma: its relationship with biological aggressiveness and G2 cyclins.
Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
Pathol Res Pract; 2003; 199(8):533-8. PubMed ID: 14533937
[TBL] [Abstract][Full Text] [Related]
10. CDK1 and cyclin A expression is linked to cell proliferation and associated with prognosis in non-Hodgkin's lymphomas.
Wolowiec D; Berger F; Ffrench P; Bryon PA; Ffrench M
Leuk Lymphoma; 1999 Sep; 35(1-2):147-57. PubMed ID: 10512172
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Oncology; 2000 Jun; 59(1):68-74. PubMed ID: 10895070
[TBL] [Abstract][Full Text] [Related]
12. Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1.
Leoncini L; Megha T; Lazzi S; Bellan C; Luzi P; Tosi P; Cevenini G; Barbini P; Ascani S; Briskomatis A; Pileri S; Kraft R; Laissue JA; Cottier H
Int J Cancer; 1998 Jul; 77(3):408-14. PubMed ID: 9663604
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
[TBL] [Abstract][Full Text] [Related]
14. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.
Kawamoto H; Koizumi H; Uchikoshi T
Am J Pathol; 1997 Jan; 150(1):15-23. PubMed ID: 9006317
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
[TBL] [Abstract][Full Text] [Related]
16. Clinical implication of cyclin B1 in non-small cell lung cancer.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Kimura Y; Uchida Y
Oncol Rep; 2003; 10(5):1381-6. PubMed ID: 12883711
[TBL] [Abstract][Full Text] [Related]
17. Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinoma.
Harada H; Omura K; Nakajima Y; Hasegawa S; Mogi S
J Exp Clin Cancer Res; 2006 Sep; 25(3):351-6. PubMed ID: 17167975
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer.
Yoshida T; Tanaka S; Mogi A; Shitara Y; Kuwano H
Ann Oncol; 2004 Feb; 15(2):252-6. PubMed ID: 14760118
[TBL] [Abstract][Full Text] [Related]
19. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
20. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.
Zhan Q; Antinore MJ; Wang XW; Carrier F; Smith ML; Harris CC; Fornace AJ
Oncogene; 1999 May; 18(18):2892-900. PubMed ID: 10362260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
